Curalogics focused on creating first in class immune therapeutics, with their lead asset targeting grass pollen allergy.
History
Liquidated
Menu
Curalogic
Pharmaceutical
×
Donald Macpherson
It is with deep sadness that we announce our dear friend and colleague Donald Macpherson passed away recently after a long illness. Donald was an enthusiastic supporter of Rosetta and we are very grateful for his advice and guidance over many years. He will be very much missed. Our thoughts and condolences go out to Donald’s family and friends during this difficult time.
